創傷治療用生物製剤の北米市場:企業概要・規模・シェア・成長・動向・予測(~2025年)

【英語タイトル】North America Wound Care Biologics Market : Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Data Bridge Market Researchが出版した調査資料(DBMR810544)・商品コード:DBMR810544
・発行会社(調査会社):Data Bridge Market Research
・発行日:2018年8月
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:北米
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可、Web Access)USD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Corporate UserUSD3,200 ⇒換算¥358,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Data Bridgeが出版した本調査レポートでは、創傷治療用生物製剤の北米市場について調査・分析し、創傷治療用生物製剤の北米市場動向、市場予測、セグメント別分析、創傷治療用生物製剤市場規模、関連企業分析などを含め以下の構成でお届けいたします。
【レポートの概要】

North America wound care biologics market is expected to grow with a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases, rising number of geriatric population, innovation in wound care biologics are fuel the growth of wound care biologics market.

The key market players for North America wound care biologics market are listed below:

• Integra LifeSciences
• ConvaTec Inc.
• AlloSource
• Amniox Medical, Inc.
• Marine Polymer Technologies, Inc.
• Solsys Medical
• ACell Inc.
• Kerecis
• WRIGHT MEDICAL GROUP N.V.
• Vericel Corporation
• Anika Therapeutics, Inc.
• Skye Biologics Inc.
• BioHorizons IPH, Inc
• Alphatec Spine, Inc.
• Amnio Technology, LLC
• Mölnlycke Health Care AB
• Smith and Nephew
• MiMedx
• Organogenesis Inc.
• Osiris Therapeutics, Inc.

The North America wound care biologics market is segmented into:
• Product Type
• Wound Type
• End User

On the basis of product type the North America wound care biologics market is segmented into synthetic skin grafts segment, growth factors segment, allografts segment, xenografts segment. In 2018, synthetic skin grafts segment is expected to dominate the North America wound care biologics market with highest market shares. However, allografts segment is expected to grow at the highest CAGR in the forecast period. Growth factors segment is further sub segmented into platelet-derived growth factor (PDGF) segment, platelet rich plasma (PRP) segment, epidermal growth factor (EGF) segment and basic fibroblast growth factor (BFGF) segment, granulocyte colony stimulating factor (G-CSF), talactoferrin alfa segment, thrombin peptide (TP508) segment, keratinocyte growth factor (KGF) segment.
On the basis of wound type the North America wound care biologics market is categorized into wounds, and ulcers, burns. In 2018, wounds segment is expected to dominate the North America wound care biologics market with the highest market shares. However, ulcers segment is expected to grow at the highest CAGR in the forecast period.
On the basis of end user North America wound care biologics market is segmented into hospitals, wound care centres and ambulatory centres, clinics, community healthcare centers. In 2018, hospitals are expected to dominate the North America wound care biologics market with the highest CAGR in the forecast period 2018 to 2025.
Based on geography, the market is segmented into 3 geographical regions:
• U.S.
• Canada
• Mexico
Covered in this report
The report covers the present scenario and the growth prospects of the North America wound care biologics market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table Of Contents
1 Introduction 30
1.1 Objectives Of The Study 30
1.2 Market Definition 30
1.3 Overview Of North America Wound Care Biologics Market 30
1.4 Currency And Pricing 31
1.5 Limitation 31
1.6 Markets Covered 32
2 Market Segmentation 34
2.1 Markets Covered 34
2.2 Geographic Scope 35
2.3 Years Considered For The Study 36
2.4 Currency And Pricing 36
2.5 Research Methodology 37
2.6 Primary Interviews With Key Opinion Leaders 40
2.1 Dbmr Market Position Grid 41
2.2 Dbmr Market Challenge Matrix 42
2.3 Secondary Sources 43
2.4 Assumptions 43
3 Market Overview 44
3.1 Drivers 46
3.1.1 Increasing Cases Of Diabetic Foot Ulcers 46
3.1.2 Increasing Incidences Of Burn Cases 46
3.1.3 Rising Number Of Geriatric Population 47
3.1.4 Innovation In Wound Care Biologics 48
3.1.5 New Product Launches 50
3.2 Restrains 50
3.2.1 High Cost Of Wound Treatment And Wound Care Biologics 50
3.2.2 Risk Of Skin Substitue Failure 51
3.3 Opportunities 52
3.3.1 3D Skin Printing 52
3.3.2 Awareness Programs 53
3.4 Challenges 54
3.4.1 Lack Of Wound Management Services 54
4 Executive Summary 55
5 Premium Insights 58
6 North America Wound Care Biologics Market, By Product Type 63
6.1 Overview 64
6.2 Synthetic Skin Grafts 66
6.3 Growth Factors 67
6.3.1 Platelet Derived Growth Factor (Pdgf) 70
6.3.2 Platelet Rich Plasma (Prp) 70
6.3.3 Epidermal Growth Factors (Egf) 70
6.3.4 Basic Fibroblast Growth Factors (Bfgf) 71
6.3.5 Granulocyte Colony Stimulating Factor (G-Csf) 71
6.3.6 Talactoferrin Alfa 71
6.3.7 Thrombin Peptide 72
6.3.8 Keratinocy Growth Factor (Kgf) 72
6.4 Allografts 73
6.5 Xenografts 74
7 North America Wound Care Biologics Market, By Wound Type 76
7.1 Overview 77
7.2 Wounds 78
7.2.1 Surgical Wound 80
7.2.1.1 Skin Surgery 81
7.2.1.1.1 Wound Closure 82
7.2.1.1.2 Skin Biopsy 82
7.2.1.1.3 Skin Flap 82
7.2.1.1.4 Skin Graft 82
7.2.1.1.5 Others 82
7.2.1.2 Cosmetic Procedure 83
7.2.1.2.1 Brest Enhancement 84
7.2.1.2.2 Facial Contouring 85
7.2.1.2.3 Facial Rejuvenation: 85
7.2.1.2.4 Body Contouring 85
7.2.1.2.5 Skin Rejuvenation 85
7.2.1.2.6 Others 86
7.2.1.3 Gynecologic Procedures 86
7.2.1.3.1 Pubovaginalis Sling 86
7.2.1.3.2 Pelvic Floor Reconstruction 87
7.2.1.3.3 Rectocele Repair Surgery 87
7.2.1.3.4 Others 87
7.2.1.4 Gastrointestinal Procedure 87
7.2.1.4.1 General Gastrointestinal Surgery 88
7.2.1.4.2 Hernia 89
7.2.1.4.3 Others 89
7.2.2 Acute Wounds 90
7.2.3 Chronic Wounds 90
7.2.4 Traumatic Wounds 91
7.3 Burns 91
7.3.1 Ulcers 92
7.3.2 Diabetic Ulcers 94
7.3.3 Pressure Ulcer 94
7.3.4 Venous Ulcer 95
7.3.5 Others 95
8 North America Wound Care Biologics Market, By End User 96
8.1 Overview 97
8.2 Hospitals 99
8.3 Wound Care Centers 100
8.4 Ambulatory Surgical Centers 101
8.5 Clinics 103
8.6 Community Healthcare Center 104
9 North America Wound Care Biologics Market: Geography 105
9.1 North America 105
9.1.1 U.S. 116
9.1.2 Canada 123
9.1.3 Mexico 130
10 North America Wound Care Biologics Market, Company Landscape 137
10.1 Company Share Analysis: North America 137
11 Company Profile 138
11.1 Mimedx. 138
11.1.1 Company Overview 138
11.1.2 Revenue Analysis: 138
11.1.3 Company Share Analysis: 139
11.1.4 Product Portfolio 139
11.1.5 Recent Developments 140
11.2 Organogenesis Inc 141
11.2.1 Company Overview 141
11.2.2 Geographic Presence 141
11.2.3 Company Share Analysis: 142
11.2.4 Product Portfolio 142
11.2.5 Recent Developments 143
11.3 Integra Lifesciences 144
11.3.1 Company Overview 144
11.3.2 Revenue Analysis 144
11.3.3 Company Share Analysis: 145
11.3.4 Product Portfolio 145
11.3.5 Recent Developments 146
11.4 Convatec Inc. 147
11.4.1 Company Overview 147
11.4.2 Revenue Analysis 147
11.4.3 Company Share Analysis: 148
11.4.4 Product Portfolio : 148
11.4.5 Recent Developments 148
11.5 Acell Inc. 149
11.5.1 Company Overview 149
11.5.2 Product Portfolio 149
11.5.3 Recent Developments 150
11.6 Allosource 151
11.6.1 Company Overview 151
11.6.2 Product Portfolio 151
11.6.3 Recent Developments 152
11.7 Alphatec Spine, Inc. ( A Subsidary Of Alphatec Holdings, Inc) 153
11.7.1 Company Overview 153
11.7.2 Product Portfolio 153
11.7.3 Recent Developments 153
11.8 Amnio Technology, Llc 154
11.8.1 Company Overview 154
11.8.2 Product Portfolio 154
11.8.3 Recent Developments 155
11.9 Amniox Medical, Inc. 156
11.9.1 Company Overview 156
11.9.2 Product Portfolio 156
11.9.3 Recent Developments 157
11.10 Anika Therapeutics, Inc. 158
11.10.1 Company Overview 158
11.10.2 Revenue Analysis 158
11.10.3 Product Portfolio 159
11.10.4 Recent Developments 159
11.11 Biohorizons Iph, Inc ( A Subsidary Of Henry Schein, Inc.) 160
11.11.1 Company Overview 160
11.11.2 Geographicpresence 160
11.11.3 Product Portfolio 161
11.11.4 Recent Developments 161
11.12 Kerecis 162
11.12.1 Company Overview 162
11.12.2 Geographical Presence 162
11.12.3 Product Portfolio 163
11.12.4 Recent Developments 163
11.13 Marine Polymer Technologies, Inc 164
11.13.1 Company Overview 164
11.13.2 Product Portfolio 164
11.13.3 Recent Developments 164
11.14 Mölnlycke Health Care Ab 165
11.14.1 Company Overview 165
11.14.2 Revenue Analysis 165
11.14.3 Product Portfolio 166
11.14.4 Recent Developments 166
11.15 Osiris Therapeutics, Inc. 167
11.15.1 Company Overview 167
11.15.2 Revenue Analysis 167
11.15.3 Product Portfolio 168
11.15.4 Recent Developments 168
11.16 Skye Biologics Inc. 169
11.16.1 Company Overview 169
11.16.2 Product Portfolio : 169
11.16.3 Recent Development: 170
11.17 Smith And Nephew 171
11.17.1 Company Overview 171
11.17.2 Revenue Analysis 171
11.17.3 Product Portfolio 172
11.17.4 Recent Developments 172
11.18 Solsys Medical. 173
11.18.1 Company Overview 173
11.18.2 Product Portfolio 174
11.18.3 Recent Developments 174
11.19 Vericel Corporation. 175
11.19.1 Company Overview 175
11.19.2 1.1.2 Revenue Analysis 175
11.19.3 Product Portfolio 176
11.19.4 Recent Developments 176
11.20 Wright Medical Group N.V 177
11.20.1 Company Overview 177
11.20.2 1.1.2 Revenue Analysis 177
11.20.3 Product Portfolio 178
11.20.4 Recent Developments 179
12 Related Reports 180

List Of Tables
Table 1 North America Wound Care Biologics Market, By Product Type, 2016– 2025 (Usd Million) 52
Table 2 North America Synthetic Skin Grafts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 53
Table 3 North America Growth Factors In Wound Care Biologics Market, By Product Type, 2016– 2025 (Usd Million) 55
Table 4 North America Growth Factors In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 56
Table 5 North America Allografts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 60
Table 6 North America Xenografts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 62
Table 7 North America Wound Care Biologics Market, By Wound Type, 2015– 2025 (Usd Million) 65
Table 8 North America Wounds In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 66
Table 9 North America Wounds In Wound Care Biologics Market, By Wound Type, 2016– 2025 (Usd Million) 66
Table 10 North America Surgical Wound In Wound Care Biologics Market, 2016-2025 (Usd Million) 67
Table 11 North America Skin Surgery In Wound Care Biologics Market, 2016-2025 (Usd Million) 68
Table 12 Number Of Cosmetic Surgery, 2016 & 2017 70
Table 13 North America Cosmetic Surgery In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million) 71
Table 14 North America Gynecologic Procedures In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million) 73
Table 15 North America Gastrointestinal Procedures In Wound Care Biologics Market, By Wound Type 2018-2025 (Usd Million) 75
Table 16 North America Burns In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 79
Table 17 North America Ulcers In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 80
Table 18 North America Ulcers In Wound Care Biologics Market, By Wound Type 2016-2025 (Usd Million) 80
Table 19 North America Wound Care Biologics Market, By End User, 2016 – 2025 (Usd Million) 85
Table 20 North America Hospitals In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 86
Table 21 North America Wound Care Center In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 87
Table 22 Statistics For Ambulatory Surgical Center. U.S. 88
Table 23 North America Ambulatory Surgical Centers In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 89
Table 24 North America Clinics In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 90
Table 25 North America Community Healthcare Center In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 91
Table 26 North America Wound Care Biologics Market, By Country, 2016-2025 (Usd Million ) 96
Table 27 North America Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 96
Table 28 North America Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 97
Table 29 North America Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 97
Table 30 North America Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 98
Table 31 North America Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 98
Table 32 North America Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 99
Table 33 North America Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 100
Table 34 North America Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 100
Table 35 North America Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 101
Table 36 North America Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 101
Table 37 North America Wound Care Biologics, By End User, 2016-2025, (Usd Million) 102
Table 38 U.S. Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 103
Table 39 U.S. Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 104
Table 40 U.S. Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 104
Table 41 U.S. Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 105
Table 42 U.S. Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 105
Table 43 U.S. Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 106
Table 44 U.S. Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 107
Table 45 U.S. Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 107
Table 46 U.S. Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 108
Table 47 U.S. Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 108
Table 48 U.S. Wound Care Biologics, By End User, 2016-2025, (Usd Million) 109
Table 49 Canada Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 110
Table 50 Canada Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 111
Table 51 Canada Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 111
Table 52 Canada Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 112
Table 53 Canada Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 112
Table 54 Canada Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 113
Table 55 Canada Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 114
Table 56 Canada Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 114
Table 57 Canada Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 115
Table 58 Canada Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 115
Table 59 Canada Wound Care Biologics, By End User, 2016-2025, (Usd Million) 116
Table 60 Mexico Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 117
Table 61 Mexico Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 118
Table 62 Mexico Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 118
Table 63 Mexico Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 119
Table 64 Mexico Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 119
Table 65 Mexico Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 120
Table 66 Mexico Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 121
Table 67 Mexico Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 121
Table 68 Mexico Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 122
Table 69 Mexico Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 122
Table 70 Mexico Wound Care Biologics, By End User, 2016-2025, (Usd Million) 123




【レポートのキーワード】

創傷治療用生物製剤

★調査レポート[創傷治療用生物製剤の北米市場:企業概要・規模・シェア・成長・動向・予測(~2025年)] (コード:DBMR810544)販売に関する免責事項を必ずご確認ください。
★調査レポート[創傷治療用生物製剤の北米市場:企業概要・規模・シェア・成長・動向・予測(~2025年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆